Answers are grounded in this paper and cite their sources.
Background To compare oncologic outcomes of high-intensity focused ultrasound (HIFU), conventional radical prostatectomy (CRP), and robotic radical prostatectomy (RRP) in Asian patients with localized prostate cancer using a large real-world dataset and propensity score–based inverse probability of treatment weighting (IPTW). Methods This retrospective cohort study included 2,239 patients with localized prostate cancer treated at Chang Gung Memorial Hospital (2001–2020): 415 with HIFU, 1,536 with RRP, and 288 with CRP. Biochemical recurrence (BCR) and all-cause mortality were assessed using Cox proportional hazards models. IPTW was performed to balance confounders between the HIFU and RRP groups. Survival outcomes were analyzed overall and across NCCN risk groups. Results RRP was associated with significantly lower risk of BCR compared with HIFU (adjusted HR 0.72; 95% CI 0.58–0.88; p=0.002). In IPTW-weighted analyses, RRP demonstrated significantly superior 5- and 10-year BCR-free and overall survival in high- and very high-risk patients. No significant differences were observed in low- and intermediate-risk patients. CRP consistently showed outcomes between RRP and HIFU but became infrequent after 2006. Conclusions In this large real-world Asian cohort, RRP provided superior oncologic outcomes compared with HIFU among high- and very high-risk patients, whereas both modalities achieved comparable outcomes in low- and intermediate-risk disease. These findings support risk-stratified treatment selection and reinforce RRP as the preferred approach for aggressive prostate cancer.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: